Longitudinal association between CSF markers of Alzheimer Disease and inflammation in preclinical Alzheimer Disease

  • Published on 01/08/2025
  •  Reading time: 4 min.

Isabel MacKenzie Sarty 1,2, Cynthia Picard 3,4, Anne Labonte 5,6, John C.S. Breitner 6,7,8, Judes Poirier 3,6,7,9

1 Integrated Program in Neuroscience, Faculty of Medicine and Health Science, McGill University, Montreal, QC Canada
2 Department of Psychiatry, McGill University, Montreal, QC Canada
3 Douglas Mental Health Research Centre, Montreal, QC Canada
4 Centre for Studies on Prevention of Alzheimer’s Disease (StoP‐AD Centre), Montréal, QC Canada
5 Centre for Studies on Prevention of Alzheimer’s disease (StoP‐AD Centre), Douglas Mental Health Institute, Montreal, QC Canada
6 Centre for Studies on Prevention of Alzheimer’s disease (StoP‐AD Centre), Montreal, QC Canada
7 Department of Psychiatry, McGill University, Montréal, QC Canada
8 Douglas Mental Health University Institute, Montréal, QC Canada
9 Department of Medicine, McGill University, Montréal, QC Canada

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Neurology

Receive our newsletter to stay up to date with the latest news in Neurology